RadNet Revenue 2010-2024 | RDNT

RadNet revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
RadNet Annual Revenue
(Millions of US $)
2023 $1,617
2022 $1,430
2021 $1,315
2020 $1,072
2019 $1,154
2018 $975
2017 $922
2016 $885
2015 $810
2014 $718
2013 $703
2012 $647
2011 $585
2010 $519
2009 $528
RadNet Quarterly Revenue
(Millions of US $)
2024-03-31 $432
2023-12-31 $420
2023-09-30 $402
2023-06-30 $404
2023-03-31 $391
2022-12-31 $384
2022-09-30 $350
2022-06-30 $354
2022-03-31 $342
2021-12-31 $333
2021-09-30 $333
2021-06-30 $334
2021-03-31 $315
2020-12-31 $308
2020-09-30 $292
2020-06-30 $191
2020-03-31 $282
2019-12-31 $301
2019-09-30 $293
2019-06-30 $289
2019-03-31 $272
2018-12-31 $257
2018-09-30 $242
2018-06-30 $244
2018-03-31 $231
2017-12-31 $236
2017-09-30 $228
2017-06-30 $230
2017-03-31 $229
2016-12-31 $225
2016-09-30 $225
2016-06-30 $219
2016-03-31 $216
2015-12-31 $216
2015-09-30 $208
2015-06-30 $204
2015-03-31 $181
2014-12-31 $186
2014-09-30 $184
2014-06-30 $179
2014-03-31 $169
2013-12-31 $178
2013-09-30 $175
2013-06-30 $177
2013-03-31 $173
2012-12-31 $159
2012-09-30 $160
2012-06-30 $165
2012-03-31 $162
2011-12-31 $150
2011-09-30 $143
2011-06-30 $148
2011-03-31 $144
2010-12-31 $115
2010-09-30 $140
2010-06-30 $139
2010-03-31 $124
2009-12-31 $135
2009-09-30 $133
2009-06-30 $131
2009-03-31 $128
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $4.232B $1.617B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.002B 10.28
Quest Diagnostics (DGX) United States $15.353B 15.87
DaVita (DVA) United States $12.299B 15.28
Elanco Animal Health (ELAN) United States $8.994B 23.33
Encompass Health (EHC) United States $8.506B 21.77
Chemed (CHE) United States $8.076B 25.03
Option Care Health (OPCH) United States $4.839B 18.32
Amedisys (AMED) United States $2.993B 21.20
Astrana Health (ASTH) United States $2.272B 30.72
LifeStance Health (LFST) United States $2.018B 0.00
Addus HomeCare (ADUS) United States $1.914B 27.38
U.S Physical Therapy (USPH) United States $1.400B 37.46
Pennant (PNTG) United States $0.662B 34.98
Aveanna Healthcare Holdings (AVAH) United States $0.491B 0.00
Atai Life Sciences (ATAI) Germany $0.223B 0.00
Daxor (DXR) United States $0.042B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Novo Integrated Sciences (NVOS) United States $0.014B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00